UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 28, 2021 4:01 P.M.

Form:	S-1
CIK: 0001816736 Company Name: Gemini Therapeutics, Inc. /DE File Number: 333-253175